{
    "ticker": "HTGMQ",
    "name": "HTG Molecular Diagnostics, Inc.",
    "description": "HTG Molecular Diagnostics, Inc. is a biotechnology company focused on providing innovative molecular diagnostic solutions for cancer, immune disorders, and other diseases. Founded in 2006 and headquartered in Tucson, Arizona, HTG utilizes its proprietary technology platform to develop and commercialize assays that enable comprehensive gene expression profiling. The company's mission is to improve patient outcomes by delivering actionable insights through its advanced molecular testing capabilities. HTG's flagship products include the HTG EdgeSeq technology, which allows for high-throughput analysis of RNA and DNA, and the HTG Transcriptome Panel, designed for RNA sequencing in various oncology applications. By empowering researchers and clinicians with precise molecular data, HTG aims to enhance the understanding of disease mechanisms and support personalized medicine initiatives. The company collaborates with leading research institutions and pharmaceutical companies to advance the field of molecular diagnostics and contribute to the future of healthcare.",
    "industry": [
        "Biotechnology",
        "Diagnostics"
    ],
    "headquarters": "Tucson, Arizona, USA",
    "founded": "2006",
    "website": "https://www.htgmolecular.com",
    "ceo": "Tracy R. D. M. M. B. Koziol",
    "social_media": {
        "twitter": "https://twitter.com/HTGMD",
        "linkedin": "https://www.linkedin.com/company/htg-molecular-diagnostics",
        "youtube": "https://www.youtube.com/channel/UC1nDgRjE6tF5kH05gCwD1Xg"
    },
    "investor_relations": "https://ir.htgmolecular.com",
    "key_executives": [
        {
            "name": "Tracy R. D. M. M. B. Koziol",
            "position": "CEO"
        },
        {
            "name": "Shawn D. E. F. D. M. M. B. Whelan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Molecular Diagnostics",
            "products": [
                "HTG EdgeSeq",
                "HTG Transcriptome Panel"
            ]
        }
    ],
    "seo": {
        "meta_title": "HTG Molecular Diagnostics, Inc. | Innovative Molecular Diagnostic Solutions",
        "meta_description": "Explore HTG Molecular Diagnostics, Inc., a leader in molecular diagnostics focusing on cancer and immune disorders. Discover their advanced technology and products.",
        "keywords": [
            "HTG Molecular Diagnostics",
            "Molecular Diagnostics",
            "Biotechnology",
            "Gene Expression Profiling",
            "Personalized Medicine"
        ]
    },
    "faq": [
        {
            "question": "What does HTG Molecular Diagnostics specialize in?",
            "answer": "HTG Molecular Diagnostics specializes in molecular diagnostic solutions for cancer and other diseases."
        },
        {
            "question": "Who is the CEO of HTG Molecular Diagnostics?",
            "answer": "Tracy R. D. M. M. B. Koziol is the CEO of HTG Molecular Diagnostics, Inc."
        },
        {
            "question": "Where is HTG Molecular Diagnostics headquartered?",
            "answer": "HTG Molecular Diagnostics is headquartered in Tucson, Arizona, USA."
        },
        {
            "question": "What are HTG's main products?",
            "answer": "HTG's main products include the HTG EdgeSeq technology and HTG Transcriptome Panel."
        },
        {
            "question": "When was HTG Molecular Diagnostics founded?",
            "answer": "HTG Molecular Diagnostics was founded in 2006."
        }
    ],
    "competitors": [
        "EXAS",
        "GNMK",
        "NVTA",
        "QGEN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "REGN"
    ]
}